# Passage BIO, Inc.: Form SCHEDULE 13D/A, filed Jul 9, 2025

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: SCHEDULE 13D/A
- Filed: 2025-07-09
- Accepted by EDGAR: Jul 9, 2025, 20:06 ET
- Period: not reported
- Accession: 0000947871-25-000657
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000094787125000657/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000094787125000657/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000094787125000657/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jul 9, 2025.
Source: SEC EDGAR, the filing index for accession 0000947871-25-000657. Last ingested by Listed: Nov 6, 2026, 11:01 ET. No prices; not investment advice.